Modelling the spread of HIV in social networks of injecting drug users

AIDS

Volumn 12, Issue 7, 1998, Pages 801-811

  Kretzschmar, Mirjam ^a,b   Wiessing, Lucas G ^a,c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

Author keywords

HIV; Injecting drug users; Networks; Prevention strategies; Stochastic simulation model

Indexed keywords

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MODEL; NEEDLE; NETHERLANDS; PRIORITY JOURNAL; STATISTICS; VIRUS TRANSMISSION;

HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; SOCIAL SUPPORT; STOCHASTIC PROCESSES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0032492958     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199807000-00017     Document Type: Article

References (40)

1. European Centre for the Epidemiological Monitoring of AIDS: HIV/AIDS Surveillance in Europe: Quarterly Report No. 54, 30 June 1997. St Maurice: European Centre for the Epidemiological Monitoring of AIDS; 1997.
2. Hahn RA, Onorato IM, Jones TS, Dougherty J: Prevalence of HIV infection among injecting drug users in the United States. JAMA 1989, 261:2677-2684.
3. Papaevangelou G, Richardson SC: HIV prevalence and risk factors among injecting drug users in EC and COST countries. In AIDS Research at EC Level. Edited by Baert AE, Koch MA, Montagnier L, Razquin MC, Tyrrell D. Amsterdam: IOS Press; 1995:73-82.
4. European Centre for the Epidemiological Monitoring of AIDS: HIV/AIDS Surveillance in Europe: 1994-1996. St Maurice: European Centre for Epidemiological Monitoring of AIDS; 1996.
5. Rezza G, De Rose A, Dorrucci M, Arpino C, Serafin I: Declining prevalence of HIV infection among injecting drug users entering drug treatment in Italy: 1990-1991. Eur J Epidemiol 1993, 9:663-666.
6. Stimson CV: AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. Soc Sci Med 1995, 41:699-716.
7. European Monitoring Centre for Drugs and Drug Addiction: 1997 Annual Report on the State of the Drugs Problem in the European Union. Lisbon: EMCDDA; 1997.
8. Rodriguez-Arenas MA, Zunzunegui Pastor MV, Friedman SR, Bellido JCR, Ward TP: Sharing syringes in Madrid: a social phenomenon, Eur J Public Health 1996, 6:11-14.
9. Des Jarlais DC, Friedman SR: Shooting galleries and AIDS: infection probabilities and 'tough' policies. Am J Public Health 1990, 80:142-144.
10. Marmor M, Des Jarlais DC, Cohen H, et al.: Risk factors for infection with human immunodeficiency virus among injecting drug abusers in New York City. AIDS 1987, 1:39-44.
11. Schoenbaum EE, Martel D, Selwyn PA, et al.: Risk factors for human immunodeficiency virus infection in injecting drug users. N Engl J Med 1989, 321:874-879.
12. Becker NG, Dietz K: The effect of household distribution on transmission and control of highly infectious diseases. Math Biosci 1995, 127:207-219.
13. Friedman SR: Theoretical bases for understanding drug users' organisations. Int J Drug Policy 1996, 7:212-219.
14. Wiessing LG, van Rozendaal CM, Scheepens JMFA, et al.: Surveillance van HIV-Infectie onder Intraveneuze Druggebruiker in Nederland: Meting Arnhem 1995. [RIVM Report 441100002l. Bilthoven: RIVM; 1996.
15. Wiessing LG, Toet J, Houweling H, Koedijk PM, van den Akker R, Sprenger MJW: Prevalentie en Risicofactoren van HIV-Infectie onder Druggebruikers, in Rotterdam. IRIVM Report 213220001l. Bilthoven: RIVM; 1995.
16. van den Hoek JAR, Coutinho RA, van Haastrecht HJA, van Zadelhoff AW, Goudsmit J: Prevalence and risk factors of HIV infection among drug users and drug-using prostitutes in Amsterdam. AIDS 1988, 2:55-60.
17. Fennema JSA, van Ameijden EJC, van den Hoek JAR, et al.: De HIV-prevalentie bij intraveneuze druggebruikers in Amsterdam: een onderzoek op straat. T Soc Gezondheidsz 1993, 71:267-272.
18. Wiessing LG, Houweling H, Spruit IP, et al.: HIV among drug users in regional towns near the initial focus of the Dutch epidemic [letter]. AIDS 1996, 10:1448-1449.
19. Wiessing LG, Houweling H, Meulders WAJ, Cerdá E, Jansen M, Sprenger MJW: Prevalence of HIV-infections among drug users in Zuid-Limburg. Ned Tijdschr Geneeskd 1995, 139:1936-1940.
20. Blower SM, Hartel D, Dowlatabadi H, Andersen RM, May RM: Drugs, sex and HIV: a mathematical model for New York City. Phil Trans R Soc Lond B 1991, 321:171-187.
21. Kretzschmar M, Reinking DP, Jager JC, Brouwers H, van Zessen C: Network models: from paradigm to mathematical tool. In Modelling the AIDS Epidemic. Edited by Kaplan EH, Brandeau M. New York: Raven Press; 1994:561-583.
22. Kretzschmar M, van Duynhoven YTHP, Severijnen AJ: Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations. Am J Epidemiol 1996, 144:306-317.
23. Longini Jr IM, Clark WS, Haber M, Horsburgh Jr R: The stages of HIV infection: waiting times and infection transmission probabilities. In Mathematical and Statistical Approaches to AIDS Epidemiology. Lecture Notes in Biomathematics Vol 83. Edited by Castillo-Chavez C. Berlin: Springer Verlag; 1989:111-137.
24. Jacquez JA, Koopman JS, Simon CP, Longini Jr IM: Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr 1994, 7:1169-1184.
25. Stramer SL, Heller JS, Coombs RW, Parry JV, Ho DD, Allain JP: Markers of HIV infection prior to IgG antibody seropositivity. JAMA 1989, 262:64-69.
26. Coombs RW, Collier AC, Allain JP, et al.: Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989, 321:1626-1631.
27. Iannelli M, Milner FA, Pugliese A, Gonzo M: The HIV/AIDS epidemics among drug injectors: a study of contact structure through a mathematical model. Math Biosci 1997, 139:25-58.
28. Kaplan EH, Heimer R: A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 1992, 5:1116-1118.
29. Bailey NTG: The Mathematical Theory of Infectious Diseases. London: Griffin; 1975.
30. van Ameijden EJC, van den Hoek JAR, Mientjes GHC, Coutinho RA: A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam, Eur J Epidemiol 1993, 9:255-262.
31. van den Hoek JAR, van Haastrecht HJA, Coutinho RA: Risk reduction among injecting drug users in Amsterdam under the influence of AIDS. Am J Public Health 1989, 79:1355-1357.
32. Friedman SR, Des Jarlais DC, Neaigus A, et al.: AIDS and the new drug injector. Nature 1989, 339:333-334.
33. Fennema JSA, van Ameijden EJC, van den Hoek JAR, Coutinho RA: Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 1997, 92:1457-1465.
34. Blower SM: Behaviour change and stabilization of seroprevalence levels in communities of injecting drug users: correlation or cause? J Acquir Immune Defic Syndr 1991, 4:920-924.
35. Lardelli P, de la Fuente L, Alonso JM, López R, Bravo MJ, Delgado-Rodríguez M: Geographical variations in the prevalence of HIV infection among drug users receiving ambulatory treatment in Spain, Int J Epidemiol 1993; 22:306-314.
36. Nicolosi A, Leite ML, Molinari S, Musicco M, Saracco A, Lazzarin A: Incidence and prevalence trends of HIV infection in intravenous drug users attending treatment centers in Milan and northern Italy, 1986-1990. J Acquir Immune Defic Syndr 1992, 5:365-373.
37. Poshyachinda V: Drugs and AIDS in Southeast Asia. Forensic Sci Int 1993, 62:1-2,15-28.
38. Khodakevich L, Kobyshcha Y, Shcherbinskaya A, Kruglov Y: Epidemiology of HIV infection among injecting drug users in Ukraine. VIII International Conference on the Reduction of Drug Related Harm. Paris, March 1997 (abstract, p106].
39. Röhrig S, Grob PJ: Infektionen mit den hepatitisviren HAV, HBV und HCV sowie mit dem Aidsvirus HIV bei drogenabhängigen der gassenszene Zürichs - eine prävalenzstudie. Schweiz Med Wochenschr 1990, 120:621-629.
40. Peterson D, Willard K, Altmann M, Gatewood L, Davidson G: Monte Carlo simulation of HIV infection in an intravenous drug user community. J Acquir Immune Defic Syndr 1990, 3:1086-1095.